FIG 2.
The actuarial probability of 30-day attributable mortality in patients with bloodstream infections (BSIs) according to strong biofilm producers (SBPs) versus weak biofilm producers (WBPs).
The actuarial probability of 30-day attributable mortality in patients with bloodstream infections (BSIs) according to strong biofilm producers (SBPs) versus weak biofilm producers (WBPs).